LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="van der Poel, Henk G"
  2. AU="Hatkin, Joshua M"
  3. AU=Mc Mahon Siobhan S.
  4. AU="Larmonier, Thierry"
  5. AU="Basu, Madhumita"
  6. AU="Smetana, Jiří"
  7. AU="Pires, Flávio Oliveira"
  8. AU="Rodrigues Bezerra, Suieny"
  9. AU="Zhang, Jinhe"
  10. AU=Cruz Juan
  11. AU="Conte, Celeste"
  12. AU="Anjume, Humaira"
  13. AU="Shunji Shiota"
  14. AU="Gaurisha Gupta"
  15. AU="Nnamani, Mauris C"
  16. AU="Wang, Daorong"
  17. AU="Peng, Huakang"
  18. AU="Soderquest, Katrina"
  19. AU="Da Cruz ESilva, C Beirão"
  20. AU="Khan-Chowdhury, N R"
  21. AU="Bartelt-Hunt, Shannon"
  22. AU=Singh Gurvinder Pal
  23. AU="Chighine, Alberto"

Search results

Result 1 - 10 of total 297

Search options

  1. Article ; Online: Reply to Liebert et al. diagnostic potential of radiological apical tumor involvement. J Robot Surg. 2022 Epub ahead of print.

    Veerman, Hans / van der Poel, Henk G

    Journal of robotic surgery

    2022  Volume 17, Issue 2, Page(s) 707

    MeSH term(s) Humans ; Robotic Surgical Procedures/methods ; Neoplasms ; Radiography
    Language English
    Publishing date 2022-06-24
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 2268283-1
    ISSN 1863-2491 ; 1863-2483
    ISSN (online) 1863-2491
    ISSN 1863-2483
    DOI 10.1007/s11701-022-01438-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Re: Apalutamide and Overall Survival in Non-metastatic Castration-resistant Prostate Cancer.

    van der Poel, Henk G

    European urology

    2020  Volume 78, Issue 1, Page(s) 116–117

    MeSH term(s) Androgen Receptor Antagonists ; Humans ; Male ; Prostatic Neoplasms, Castration-Resistant ; Thiohydantoins
    Chemical Substances Androgen Receptor Antagonists ; Thiohydantoins ; apalutamide
    Language English
    Publishing date 2020-03-12
    Publishing country Switzerland
    Document type Journal Article ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2020.02.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: External Validation of a Prediction Model for Side-specific Extraprostatic Extension of Prostate Cancer at Robot-assisted Radical Prostatectomy.

    Veerman, Hans / Heymans, Martijn W / van der Poel, Henk G

    European urology open science

    2022  Volume 37, Page(s) 50–52

    Abstract: The aim of this study was to externally validate a nomogram for side-specific extraprostatic extension (EPE) of prostate cancer (PCa) at robot-assisted radical prostatectomy (RARP). A prospectively maintained cohort of 1170 consecutive patients with PCa ... ...

    Abstract The aim of this study was to externally validate a nomogram for side-specific extraprostatic extension (EPE) of prostate cancer (PCa) at robot-assisted radical prostatectomy (RARP). A prospectively maintained cohort of 1170 consecutive patients with PCa who underwent RARP at two high-volume RARP centres between 2018 and 2021 was retrospectively evaluated. Biopsies and magnetic resonance imaging (MRI) scans were centrally reviewed. The side-specific probability of EPE was calculated for each prostate side using prostate-specific antigen density, ipsilateral highest biopsy Gleason score, and ipsilateral MRI tumour stage. Model discrimination and calibration were analysed using the area under the receiver operating characteristic curve (AUC), calibration in the large, and calibration curves. The rate of side-specific EPE was 30% among 2254 prostate sides; the mean predicted rate was also 30%. The discriminatory value of the model was good, with an AUC of 80.4% (interquartile range 78.4-82.3%). The predicted probabilities matched the observed probabilities well (intercept -0.02, slope 1.053). There was slight underestimation of the observed probabilities from 70% upwards. In conclusion, an easy-to-use nomogram for side-specific EPE at RARP was externally validated and can be applied to virtually all PCa patients.
    Patient summary: A prediction model used to decide whether to spare the neurovascular bundles during removal of the prostate can be applied to virtually all prostate cancer patients.
    Language English
    Publishing date 2022-02-02
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3040546-4
    ISSN 2666-1683 ; 2058-4881
    ISSN (online) 2666-1683
    ISSN 2058-4881
    DOI 10.1016/j.euros.2021.12.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Oligometastases: the art of providing metastases-directed therapy in prostate cancer.

    van Leeuwen, Fijs W B / van der Poel, Henk G

    Nature reviews. Urology

    2022  Volume 19, Issue 5, Page(s) 259–260

    MeSH term(s) Humans ; Male ; Neoplasm Metastasis ; Prostatic Neoplasms/surgery ; Radiosurgery ; Retrospective Studies
    Language English
    Publishing date 2022-01-24
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 2493737-X
    ISSN 1759-4820 ; 1759-4812
    ISSN (online) 1759-4820
    ISSN 1759-4812
    DOI 10.1038/s41585-022-00570-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019.

    Grivas, Nikolaos / van der Poel, Henk G

    European urology focus

    2021  Volume 8, Issue 3, Page(s) 887

    MeSH term(s) Humans ; Laparoscopy ; Nephrectomy ; Robotic Surgical Procedures ; Robotics
    Language English
    Publishing date 2021-05-18
    Publishing country Netherlands
    Document type Letter ; Comment
    ISSN 2405-4569
    ISSN (online) 2405-4569
    DOI 10.1016/j.euf.2021.04.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl).

    van Rossum, Huub H / van Winden, Lennart J / Bergman, Andries M / van der Poel, Henk G

    European urology open science

    2023  Volume 48, Page(s) 98–100

    Abstract: Testosterone measurements are essential in the management of patients with prostate cancer undergoing castration and androgen deprivation therapy. There has been an ongoing discussion on the testosterone castration cutoff (TCC), with the primary focus on ...

    Abstract Testosterone measurements are essential in the management of patients with prostate cancer undergoing castration and androgen deprivation therapy. There has been an ongoing discussion on the testosterone castration cutoff (TCC), with the primary focus on large cohort studies in which the testosterone measurement system was not specified or studies that used individual testosterone measurement systems. Here we present a post hoc analysis of a study comparing testosterone measurement systems in a cohort of 120 castrated patients with prostate cancer. We investigated the suitability of general, measurement system-independent, TCC values recommended in all clinical guidelines. We show that the four testosterone immunoassays commonly used are unsuitable to support lowering of TCC to 0.7 nmol/l (20 ng/dl) testosterone, since testosterone levels are falsely quantified as higher than this cutoff in 4.2-29.2% of the castrated cohort, depending on the testosterone immunoassay used. When using 1.0 nmol/l (30 ng/dl) as the TCC for the Beckman immunoassay, 13.3% of the results were falsely quantified as being higher than this value. The results suggest that the measurement systems used in current practice do not support lowering the TCC to 0.7 nmol/l. Furthermore, a more local, immunoassay-dependent TCC should be considered.
    Patient summary: Patients with advanced prostate cancer who are treated to reduce their testosterone to a castration level are monitored using testosterone measurements. The testing systems currently used for measurement do not support lowering of the testosterone cutoff value to 0.7 nmol/l. Testosterone cutoff values to define castration status should preferably be based on the measurement system in local use.
    Language English
    Publishing date 2023-01-09
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 3040546-4
    ISSN 2666-1683 ; 2058-4881
    ISSN (online) 2666-1683
    ISSN 2058-4881
    DOI 10.1016/j.euros.2022.12.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Abandon the Label of Clinically Insignificant Prostate Cancer.

    Mertens, Laura S / van Leeuwen, Pim J / van der Poel, Henk G

    European urology open science

    2022  Volume 37, Page(s) 36–37

    Language English
    Publishing date 2022-01-22
    Publishing country Netherlands
    Document type Editorial
    ISSN 2666-1683
    ISSN (online) 2666-1683
    DOI 10.1016/j.euros.2021.12.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates.

    Veerman, Hans / Vis, André N / Donswijk, Maarten / van der Poel, Henk G

    Journal of personalized medicine

    2022  Volume 12, Issue 5

    Abstract: With interest, we read the article by Rosenzweig et al. [ ... ]. ...

    Abstract With interest, we read the article by Rosenzweig et al. [...].
    Language English
    Publishing date 2022-05-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2662248-8
    ISSN 2075-4426
    ISSN 2075-4426
    DOI 10.3390/jpm12050800
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top